| scholarly article | Q13442814 |
| P356 | DOI | 10.1590/S0100-879X2008001200010 |
| P8608 | Fatcat ID | release_o5m57cfe2vcunplebewfsqosd4 |
| P698 | PubMed publication ID | 19148373 |
| P5875 | ResearchGate publication ID | 23792263 |
| P2093 | author name string | A S Cunha | |
| A S Lima | |||
| E G Vilela | |||
| H O G Torres | |||
| M L A Ferrari | |||
| P2860 | cites work | Changes in gastrointestinal permeability in celiac disease | Q33595953 |
| Intestinal permeation and gastrointestinal disease | Q34119853 | ||
| Assessing the site of increased intestinal permeability in coeliac and inflammatory bowel disease | Q34409811 | ||
| In vitro determination of small intestinal permeability: demonstration of a persistent defect in patients with coeliac disease | Q34525160 | ||
| Alterations in intestinal permeability | Q34565345 | ||
| The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn's disease | Q35423622 | ||
| The immune response in inflammatory bowel disease | Q36846736 | ||
| Abnormal intestinal permeability to sugars in villous atrophy | Q39574361 | ||
| Interferon-gamma and tumor necrosis factor-alpha disrupt epithelial barrier function by altering lipid composition in membrane microdomains of tight junction | Q40061268 | ||
| Intestinal permeability: an overview | Q40513474 | ||
| Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease | Q41965718 | ||
| Influence of Saccharomyces boulardii on the intestinal permeability of patients with Crohn's disease in remission | Q46515415 | ||
| Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. | Q53912466 | ||
| A simple classification of Crohn's disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. | Q55033683 | ||
| Intestinal permeability: functional assessment and significance | Q55036938 | ||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Crohn's disease | Q1472 |
| D-(-)-mannitol | Q407646 | ||
| β-lactulose | Q422689 | ||
| P304 | page(s) | 1105-1109 | |
| P577 | publication date | 2008-12-01 | |
| P1433 | published in | Brazilian Journal of Medical and Biological Research | Q2025772 |
| P1476 | title | Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects | |
| P478 | volume | 41 |
| Q50894114 | A method for assessing real time rates of dissolution and absorption of carbohydrate and other food matrices in human subjects. |
| Q57839976 | Are alterations of tight junctions at molecular and ultrastructural level different in duodenal biopsies of patients with celiac disease and Crohn's disease? |
| Q40371820 | Assessment of the Intestinal Barrier with Five Different Permeability Tests in Healthy C57BL/6J and BALB/cJ Mice |
| Q86486414 | Changes in intestinal permeability after Roux-en-Y gastric bypass |
| Q38687215 | Chasing a ghost?--Issues with the determination of circulating levels of endotoxin in human blood. |
| Q39463126 | Combat-training increases intestinal permeability, immune activation and gastrointestinal symptoms in soldiers |
| Q35786074 | Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity? |
| Q30826823 | Environmental Enteric Dysfunction Is Associated With Poor Linear Growth and Can Be Identified by Host Fecal mRNAs |
| Q34343642 | Improvement of intestinal permeability with alanyl-glutamine in HIV patients: a randomized, double blinded, placebo-controlled clinical trial |
| Q28067113 | Intestinal permeability in a patient with liver cirrhosis |
| Q42936889 | Intestinal permeability in leukemic patients prior to chemotherapy |
| Q57113492 | Intestinal permeability in subjects from two different race groups with diverse stone-risk profiles |
| Q35322779 | The MAL-ED study: a multinational and multidisciplinary approach to understand the relationship between enteric pathogens, malnutrition, gut physiology, physical growth, cognitive development, and immune responses in infants and children up to 2 yea |
Search more.